Drug dosage individualization based on a random-effects linear model (Q34261199)

1 August 2017

title

Drug dosage individualization based on a random-effects linear model (English)

1 reference

1 August 2017

Francisco J Diaz

1

1 reference

1 August 2017

Myladis R Cogollo

2

1 reference

1 August 2017

Edoardo Spina

3

1 reference

1 August 2017

Vincenza Santoro

4

1 reference

1 August 2017

Diego M Rendon

5

1 reference

1 August 2017

Jose de Leon

6

1 reference

1 August 2017

publication date

1 January 2012

1 reference

Journal of Biopharmaceutical Statistics

1 August 2017

published in

1 reference

1 August 2017

volume

22

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

463-484

1 reference

Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

A clinical study of the association of antipsychotics with hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Individualizing drug dosage by using a random intercept linear model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Models for the incubation of AIDS and variations according to age and period

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Guidelines for the use of clozapine in individuals with developmental disabilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

Population pharmacokinetics. Theory and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543406.2010.547264

10.1080/10543406.2010.547264

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference